-
Cramer: Small-Cap Biotechs Are Reserved For Speculative Investors
Friday, July 14, 2017 - 1:18pm | 453Read More...Shares of Alder Biopharmaceuticals Inc (NASDAQ: ALDR) is clinical-stage biopharmaceutical company whose lead pivotal-stage product candidate, eptinezumab, is used for the treatment of migraines. The company is also one that ordinary investors should consider passing on, according to CNBC's Jim...
-
Alder Biopharma Surged 60% Following Phase 2 Results
Monday, March 28, 2016 - 11:15am | 272Read More...Shares of Alder Biopharmaceuticals Inc (NASDAQ: ALDR), a clinical-stage biopharmaceutical company, surged higher by nearly 60 percent on Monday. Alder Biopharmaceuticals announced earlier in the morning positive top-line data from 2 clinical trials which studied its ALD403 product, an antibody...
